Sign In
Buy ILMN
$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
Illumina (ILMN) Shares Slip on GRAIL Buyout Deal Completion
03:05am, Monday, 23'rd Aug 2021
Illumina (ILMN) acquisition of GRAIL will expand patient access to life-saving multi-cancer early-detection test.
Illumina CEO on why the company moved forward with Grail deal, in spite of FTC challenge
05:15pm, Friday, 20'th Aug 2021
Frances deSouza, Illumina CEO, joins Power Lunch to discuss his company's deal to buy cancer diagnostics company Grail, in spite of a challenge from the FTC. For access to live and exclusive video fro
Illumina in EU antitrust sights over premature $8 billion Grail deal
06:27am, Friday, 20'th Aug 2021
U.S. life sciences company Illumina could face a hefty fine for jumping the gun by completing its $8 billion cash-and-stock takeover of cancer detection test maker Grail without first securing EU anti
Illumina's stock suffering biggest selloff in a year after warning of fines for closing GRAIL merger too soon
01:55pm, Thursday, 19'th Aug 2021
Shares of Illumina Inc. ILMN, -9.86% tumbled 9.8% in afternoon trading Thursday, enough to pace the S&P 500's SPX, +0.01% decliners, after the life sciences tools disclosed that it is likely to be fin
Illumina Completes Grail Buyout Despite Uncertainty In Regulatory Process
09:49am, Thursday, 19'th Aug 2021
In defiance of FTC and EU scrutiny, Illumina Inc (NASDAQ: ILMN) went ahead to complete its $8 billion acquisition of Grail. The finalization of the buyout comes as the FTC sued to block the move i
Illumina closes $7.1 billion deal for cancer test maker Grail amid regulatory hurdles
06:54pm, Wednesday, 18'th Aug 2021
Illumina Inc has completed its $7.1 billion acquisition of cancer detection test maker Grail Inc, it said on Wednesday amid challenges posed by the U.S. Federal Trade Commission and the European Union
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
04:38pm, Wednesday, 18'th Aug 2021
SAN DIEGO, Aug. 18, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers, b
Illumina Delivers a Beat and a Raise in Q2
08:12am, Saturday, 14'th Aug 2021
According to CEO Francis deSouza, the genetic life-sciences company is "firing on all cylinders."
EU Regulators Temporarily Pause Illumina, Grail Deal Investigation
03:21pm, Thursday, 12'th Aug 2021
The European Commission has temporarily suspended the provisional deadline for its investigation into Illumina Inc's (NASDAQ: ILMN) plans to buy Grail Inc, adding uncertainty to whether regulators
What Does the Future Look Like for Illumina Stock?
06:00am, Wednesday, 11'th Aug 2021
The leader in the genomics space is being treated like a monopoly, and is now running into federal regulation and oversight.
Why Does Illumina Want to Reunite With Grail?
05:00pm, Sunday, 08'th Aug 2021
The genomics leader might be hitting a ceiling in its original business.
Illumina (ILMN) Q2 Earnings Top Estimates, 2021 View Up
11:30am, Friday, 06'th Aug 2021
Year-over-year improvement in segmental revenues in Q2 across all geographies exceeds Illumina's (ILMN) expectations.
Illumina Stock Will Be Unstoppable Once the Grail Acquisition Gets Approved
09:06am, Friday, 06'th Aug 2021
Illumina will likely be allowed to buy Grail. But even without that deal, ILMN stock is very attractive, given the company's strong growth drivers.
Illumina Q2 Earnings Boosted By Robust Growth In Core Sequencing Business; Uplifts FY21 Outlook
07:55am, Friday, 06'th Aug 2021
Illumina Inc (NASDAQ: ILMN) reported after the close of the market on Thursday that its second-quarter revenues grew 78% Y/Y to $1.13 billion, beating the consensus of $1.01 billion, driven by stren
Illumina's (ILMN) CEO Francis deSouza on Q2 2021 Results - Earnings Call Transcript
10:24pm, Thursday, 05'th Aug 2021
Illumina's (ILMN) CEO Francis deSouza on Q2 2021 Results - Earnings Call Transcript
